Legal Representation
Attorney
DEBORAH A PEACOCK
USPTO Deadlines
Next Deadline
1556 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 1999-11-02)
Due Date
November 02, 2029
Grace Period Ends
May 02, 2030
Application History
23 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 13, 2008 | C8.. | O | CANCELLED SEC. 8 (6-YR) | Loading... |
Jun 23, 2006 | CFIT | O | CASE FILE IN TICRS | Loading... |
Oct 14, 2004 | CAND | T | CANCELLATION DENIED NO. 999999 | Loading... |
Oct 14, 2004 | CANT | T | CANCELLATION TERMINATED NO. 999999 | Loading... |
Oct 14, 2004 | CANT | T | CANCELLATION TERMINATED NO. 999999 | Loading... |
Aug 14, 2003 | I | PAPER RECEIVED | Loading... | |
Jun 7, 2001 | CAND | T | CANCELLATION DENIED NO. 999999 | Loading... |
Jun 7, 2001 | CANT | T | CANCELLATION TERMINATED NO. 999999 | Loading... |
Dec 16, 1999 | PETC | T | CANCELLATION INSTITUTED NO. 999999 | Loading... |
Nov 2, 1999 | R.SR | A | REGISTERED-SUPPLEMENTAL REGISTER | Loading... |
Aug 2, 1999 | IUAA | P | USE AMENDMENT ACCEPTED | Loading... |
Aug 2, 1999 | CNTA | O | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | Loading... |
Jul 28, 1999 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
Feb 11, 1999 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
Jan 30, 1999 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 4, 1999 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 17, 1998 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
Jun 3, 1998 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 28, 1997 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
Nov 24, 1997 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Nov 4, 1997 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 27, 1997 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE | Loading... |
Oct 9, 1997 | IUAF | S | USE AMENDMENT FILED | Loading... |
Additional Information
Pseudo Mark
LOVE LACE CLINICAL
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CLINICAL TRIALS"